Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator and beta-adrenergic agonist. Its mechanism of action is thought to involve direct relaxation of vascular smooth muscle and possibly uterine smooth muscle.
## Primary Indications
* Intermittent claudication due to peripheral vascular disease.
* Historically used for threatened premature labor, but this use is not widely supported by current evidence and is generally not recommended.
## Adult Dosing
* **Intermittent Claudication:** Typically initiated at 10-20 mg orally three to four times daily. Doses may be increased to 40 mg orally three to four times daily.
* **Maximum Dose:** No specific maximum dose is established, but doses exceeding 120 mg daily are generally not recommended due to increased risk of adverse effects.
## Pediatric Dosing
* **Established pediatric dosing is not available.** Use in pediatric patients is generally not recommended.
## Dose Adjustments
* **Hepatic Impairment:** No specific dose adjustments are established. Caution advised as the drug is metabolized in the liver.
* **Renal Impairment:** No specific dose adjustments are established. Caution advised as the drug and its metabolites are excreted renally.
## Contraindications
* Do not administer to patients who are hypotensive.
* Hypersensitivity to isoxsuprine hydrochloride.
* Do not administer intravenously.
## Adverse Effects
* **Common:** Nausea, vomiting, dizziness, flushing, weakness, abdominal distress, rash.
* **Cardiovascular:** Hypotension, tachycardia, palpitations, chest pain, drowsiness.
* **Gastrointestinal:** Dry mouth.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the effects of antihypertensive medications, leading to excessive hypotension. Closely monitor blood pressure.
* **Other Vasodilators:** Concomitant use with other vasodilators may increase the risk of hypotension.
## Monitoring
* **Blood Pressure:** Monitor closely for hypotension, especially upon initiation and dose increases, and when used with other antihypertensives.
* **Symptoms:** Assess for improvement in claudication symptoms.
* **Adverse Effects:** Monitor for common and cardiovascular adverse effects.
## Clinical Pearls
* Effectiveness in intermittent claudication can be variable and may take several weeks to become apparent.
* The drug is not a substitute for aggressive risk factor management in peripheral vascular disease (e.g., smoking cessation, diabetes control, lipid management).
* Due to limited evidence and potential adverse effects, its use in premature labor is generally discouraged and not recommended by many professional organizations.
***
**Disclaimer:** This information is intended for healthcare professionals. Prescribing information can change. Always verify current prescribing information and consult with a qualified healthcare provider before making any treatment decisions.
